This could be explained by a finding that obese patients with MASLD have increased IFNα and decreased IFNγ levels, and IFNα but not IFNγ levels are associated with the accumulation of intramuscular fat, an important contributor to insulin resistance [59]. This evidence concerns the gene IFNA1 and Insulin resistance.